These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 8962328)

  • 1. Chronic effect of a high-protein low-fat diet in transplant patients.
    Borges W; González Caraballo Z; Delpín EA; Morales Otero L
    Transplant Proc; 1996 Dec; 28(6):3400-1. PubMed ID: 8962328
    [No Abstract]   [Full Text] [Related]  

  • 2. A prospective trial of a steroid-free/calcineurin inhibitor minimization regimen in human leukocyte antigen (HLA)-identical live donor renal transplantation.
    Walker JK; Alloway RR; Roy-Chaudhury P; Mogilishetty G; Cardi MA; Weimert NA; Rike AH; First MR; Woodle ES
    Transplantation; 2009 Feb; 87(3):408-14. PubMed ID: 19202447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid profile in renal transplant recipients under various immunosuppressive regimens.
    Montagnino G; Tarantino A; Aroldi A; Banfi G; Cesana B; Ponticelli C
    Transplant Proc; 1994 Oct; 26(5):2634-6. PubMed ID: 7940821
    [No Abstract]   [Full Text] [Related]  

  • 4. National Transplantation Pregnancy Registry (NTPR): cyclosporine dosing and pregnancy outcome in female renal transplant recipients.
    Armenti VT; Jarrell BE; Radomski JS; McGrory CH; Gaughan WJ; Moritz MJ
    Transplant Proc; 1996 Aug; 28(4):2111-2. PubMed ID: 8769170
    [No Abstract]   [Full Text] [Related]  

  • 5. Renal transplantation and dyslipidemia: characterization of a population and treatment with diet and low dose lovastatin.
    Downey P; Maiz A; Vaccarezza A; Pinto C; Retamal F; Martínez L
    Transplant Proc; 1995 Apr; 27(2):1803-5. PubMed ID: 7725511
    [No Abstract]   [Full Text] [Related]  

  • 6. Small dense low-density lipoprotein in renal transplant recipients: a potential target for prevention of cardiovascular complications?
    Badiou S; Garrigue V; Dupuy AM; Chong G; Cristol JP; Mourad G
    Transplant Proc; 2006 Sep; 38(7):2314-6. PubMed ID: 16980076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein abnormalities in long-term stable liver and renal transplanted patients. A comparative study.
    Fernández-Miranda C; de la Calle A; Morales JM; Guijarro C; Aranda JL; Gómez-Sanz R; Gómez-Izquierdo T; Larumbe S; Moreno E; Rodicio JL; del Palacio A
    Clin Transplant; 1998 Apr; 12(2):136-41. PubMed ID: 9575402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dilemma: maintenance therapy enhances sclerogenic risk profile.
    Jacobs U; Klein B; Miersch WD; Molitor D; Klehr HU
    Transplant Proc; 1996 Dec; 28(6):3227-30. PubMed ID: 8962249
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion.
    Thervet E; Pfeffer P; Scolari MP; Toselli L; Pallardó LM; Chadban S; Pilmore H; Connolly J; Buchler M; Schena FP; Carreño CA; Dandavino R; Cole E
    Transplantation; 2003 Sep; 76(6):903-8. PubMed ID: 14508352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of lipoproteins on cyclosporine pharmacokinetics and biological activity in transplant patients.
    Awni WM; Heim-Duthoy K; Kasiske BL
    Transplant Proc; 1990 Jun; 22(3):1193-6. PubMed ID: 2349681
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of calcineurin inhibitors on low-density lipoprotein oxidation.
    Cofan F; Cofan M; Campos B; Guerra R; Campistol JM; Oppenheimer F
    Transplant Proc; 2005 Nov; 37(9):3791-3. PubMed ID: 16386540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute allograft rejection following conversion to a new cyclosporine formulation in pediatric renal transplant patients.
    Crocker J; Renton K; Wade A; McLellan H; Acott P
    Transplant Proc; 1998 Aug; 30(5):2002-5. PubMed ID: 9723369
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term evolution of body composition after renal transplantation: 5-year survey.
    Moreau K; Chauveau P; Martin S; El-Haggan W; Barthe N; Merville P; Aparicio M
    J Ren Nutr; 2006 Oct; 16(4):291-9. PubMed ID: 17046612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid metabolic abnormalities after renal transplantation under cyclosporine and prednisone immunosuppression.
    Castelao AM; Barberá MJ; Blanco A; Fiol C; Griñó JM; Bover J; GilVernet S; Andrés E; Serón D; Castiñeiras MJ
    Transplant Proc; 1992 Feb; 24(1):96-8. PubMed ID: 1539356
    [No Abstract]   [Full Text] [Related]  

  • 15. Sequential analysis of the lipid profile of children post-renal transplantation.
    Singh A; Tejani C; Benfield M; Tejani A
    Pediatr Transplant; 1998 Aug; 2(3):216-23. PubMed ID: 10084746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of C0 and C2 levels with lipid profiles in adolescent renal transplant recipients in the early and late posttransplant periods.
    Soylu A; Kavukçu S; Türkmen MA; Kasap B; Soylu A; Bora S; Gülay H
    Transplant Proc; 2006 Jun; 38(5):1286-9. PubMed ID: 16797283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of atorvastatin therapy and conversion to tacrolimus on hypercholesterolemia and endothelial dysfunction after renal transplantation.
    Wissing KM; Unger P; Ghisdal L; Broeders N; Berkenboom G; Carpentier Y; Abramowicz D
    Transplantation; 2006 Sep; 82(6):771-8. PubMed ID: 17006324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of variability of cyclosporine pharmacokinetics on long-term renal allograft survival.
    Markell MS; Homel P; Sumrani N; Hong JH; Distant DA; Miles AM; Sommer BG; Friedman EA
    Transplant Proc; 1998 Aug; 30(5):1980-2. PubMed ID: 9723360
    [No Abstract]   [Full Text] [Related]  

  • 19. [Slowing progression of chronic allograft nephropathy by conversion from cyclosporin A to tacrolimus].
    Peng LK; Xie XB; Peng FH; Wang Y; Jiang Y; Lan GB; Fang CH; Nie MH
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 32(1):59-62. PubMed ID: 17344588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-density lipoprotein oxidizability and the alteration of its fatty acid content in renal transplant recipients treated with cyclosporine/tacrolimus.
    Bakar F; Keven K; Dogru B; Aktan F; Erturk S; Tuzuner A; Erbay B; Nebioglu S
    Transplant Proc; 2009 Jun; 41(5):1630-3. PubMed ID: 19545695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.